US01609W1027 - ADR
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 717.289B 40.72% | 853.062B 18.93% | 868.687B 1.83% | 960.244B 10.54% | |||||||
EBITDA YoY % growth | 139.275B 0.95% | 143.589B 3.10% | 151.136B 5.26% | 197.12B 30.43% | N/A | ||||||
EBIT YoY % growth | 91.366B -4.36% | 95.524B 4.55% | 104.198B 9.08% | 161.256B 54.76% | |||||||
Operating Margin | 12.74% | 11.20% | 11.99% | 16.79% | |||||||
EPS YoY % growth | 65.14 22.81% | 52.62 -19.22% | 54.57 3.71% | 64.35 17.92% | N/A |
All data in CNY
Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 10.38 -3.11% | ||||||||
Revenue Q2Q % growth | 224.055B 7.62% | ||||||||
EBITDA Q2Q % growth | 33.887B | ||||||||
EBIT Q2Q % growth | 26.162B 71.67% |
All data in CNY
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q3 2024 Q2Q % growth | 18.97 -1.51% | 19.56 | -0.59 | -3.01% |
Q2 2024 Q2Q % growth | 15.63 20.98% | 15.68 | -0.05 | -0.31% |
Q1 2024 Q2Q % growth | 17.37 48.72% | 14.81 | 2.56 | 17.30% |
Q4 2023 Q2Q % growth | 10.71 34.72% | 9.60 | 1.11 | 11.54% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q3 2024 Q2Q % growth | 260.348B 5.08% | 267.308B | -6.96B | -2.60% |
Q2 2024 Q2Q % growth | 224.79B 8.50% | 228.806B | -4.016B | -1.76% |
Q1 2024 Q2Q % growth | 234.156B 13.91% | 229.415B | 4.741B | 2.07% |
Q4 2023 Q2Q % growth | 208.2B 2.03% | 214.459B | -6.259B | -2.92% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | -8.02% | -18.33% | 0.31% | -4.71% |
Revenue | 0.03% | -1.46% | 0.2% | -1.54% |